TL;DR
Luteolin is a naturally occurring flavone with one of the broadest mechanism-of-action portfolios in the flavonoid family. The bulk of human and preclinical work supports anti-inflammatory, antioxidant, and neuroprotective claims; emerging work targets cardiovascular and uric-acid pathways. For formulators, the practical decisions are: (a) which source plant (we extract primarily from chrysanthemum and perilla), (b) which purity grade (95%, 98%, or 99.5% HPLC), and (c) whether to use the free aglycone or the water-soluble glucoside form. See our Luteolin product page for spec, COA, and bulk pricing.
Chemistry
- Systematic name: 3',4',5,7-tetrahydroxyflavone
- CAS: 491-70-3
- Molecular formula: C₁₅H₁₀O₆
- Molecular weight: 286.24 g/mol
- Appearance: Yellow crystalline powder
- Solubility: Soluble in DMSO and ethanol; very low water solubility
Luteolin is a flavone (4H-chromen-4-one backbone) bearing four hydroxyl groups. Its planar structure and hydroxyl pattern give it strong free-radical scavenging capability and the ability to chelate transition metal ions — properties that underlie both its antioxidant activity and its inhibition of metal-dependent enzymes like xanthine oxidase.
Natural sources
Luteolin is widespread in the plant kingdom, but content varies dramatically:
| Plant | Latin | Part used | Typical content |
|---|---|---|---|
| Chrysanthemum | Chrysanthemum morifolium | Flower | 0.3–1.2% |
| Perilla | Perilla frutescens | Leaf | 0.1–0.5% |
| Celery | Apium graveolens | Leaf | trace |
| Parsley | Petroselinum crispum | Leaf | 0.06% |
| Honeysuckle | Lonicera japonica | Flower | 0.1–0.3% |
| Japanese pagoda tree | Sophora japonica | Flower bud | <0.1% |
Chrysanthemum is the practical commercial choice — high content, stable supply chain, and mature standardized extraction.
Health benefits, by evidence tier
Strong preclinical + supportive human data
- Anti-inflammatory — inhibits NF-κB, MAPK (JNK/p38), STAT3, reducing TNF-α, IL-6, and NO in activated macrophages 1
- Antioxidant — scavenges DPPH, ABTS, hydroxyl radicals; activates Nrf2/ARE/HO-1 pathway 1
- Anti-allergic — suppresses mast cell degranulation and histamine release
Robust preclinical, limited human studies
- Neuroprotective — reduces β-amyloid aggregation and tau hyperphosphorylation in dementia models 2
Emerging
- Uric-acid lowering via xanthine oxidase inhibition
- Skin — soothes irritation, supports skin wellness formulations
Typical dosage
Published clinical work uses 100–300 mg/day of standardized luteolin (≥95% HPLC). Always validate against the regulatory framework and intended claims for your target market.
To improve oral bioavailability, formulators commonly use:
- Phospholipid complexes (lecithin–luteolin) — improves absorption ~3×
- Co-administration with piperine — inhibits Phase II metabolism
- Glucoside forms — luteolin-7-O-glucoside is water-soluble and absorbed differently than the aglycone
Regulatory & safety
- Generally regarded as safe at typical dietary supplement dosages
- No US FDA GRAS letter as of 2026; EFSA has not issued a novel food authorization
- Always include a
not intended to diagnose, treat, cure, or prevent any diseasedisclaimer in supplement marketing
Buying bulk luteolin
When sourcing bulk luteolin, the key qualification questions are:
- Purity by HPLC — request a recent COA with HPLC chromatogram, not just a UV summary
- Source plant — chrysanthemum vs perilla vs Japanese pagoda; affects flavonoid by-product profile
- Solvent residues — ICH Q3C compliance, especially for ethanol/methanol
- Heavy metals & pesticides — ICP-MS verification, USP <232>/<233> for pharma applications
- Microbial limits — USP <61> and <62> for supplement-grade
- Country of origin — for tariff/SOO documentation and audit trails
- Allergen statement — Sophora japonica is a legume
Get a quote from GreeneryBio →
References
Footnotes
-
Aziz N, Kim MY, Cho JY (2018). Anti-inflammatory effects of luteolin: A review. J Ethnopharmacol. doi:10.1016/j.jep.2018.07.005 ↩ ↩2
-
Nabavi SF et al. (2015). Luteolin as an anti-inflammatory and neuroprotective agent. Brain Res Bull. doi:10.1016/j.brainresbull.2015.01.001 ↩